| scholarly article | Q13442814 |
| P2093 | author name string | Adam M H Young | |
| Christopher S Ogilvy | |||
| Surya K Karri | |||
| Ninghui Zhao | |||
| P2860 | cites work | Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development | Q24317590 |
| Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells | Q28305879 | ||
| Elevation of CRABP-I in the Cerebrospinal Fluid of Patients With Moyamoya Disease | Q33194727 | ||
| Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. | Q33597563 | ||
| Culture of dendritic cells in vitro and its anti-tumor immunotherapy | Q33647252 | ||
| Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. | Q34065715 | ||
| A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. | Q34147943 | ||
| Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. | Q34388898 | ||
| Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy | Q35101021 | ||
| The chemokine system -- a major regulator of angiogenesis in health and disease | Q35962626 | ||
| Vascular repair by endothelial progenitor cells | Q37113091 | ||
| Moyamoya disease: current concepts and future perspectives | Q37305024 | ||
| Moyamoya: epidemiology, presentation, and diagnosis | Q37766328 | ||
| Moyamoya disease: a review of histopathology, biochemistry, and genetics. | Q37883351 | ||
| Role of colony-stimulating factors in atherosclerosis | Q38042312 | ||
| Potential efficacy of basic fibroblast growth factor incorporated in biodegradable hydrogels for skull bone regeneration | Q38558321 | ||
| Childhood moyamoya disease. | Q38605947 | ||
| A natural anti-inflammatory enone fatty acid inhibits angiogenesis by attenuating nuclear factor-κB signaling in vascular endothelial cells | Q39623667 | ||
| Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. | Q40402637 | ||
| Janus kinase 2 is involved in lipopolysaccharide-induced activation of macrophages | Q40657235 | ||
| A pivotal role for TGF-beta in atherogenesis? | Q40926437 | ||
| Aberrant activation of JAK/STAT pathway components in response to G-CSF, interferon-alpha/beta and interferon-gamma in NFS-60 cells | Q41245191 | ||
| Basic fibroblast growth factor bound to cell substrate promotes cell adhesion, proliferation, and protease production in cultured endothelial cells | Q41645536 | ||
| Therapeutic Effects of Acupuncture through Enhancement of Functional Angiogenesis and Granulogenesis in Rat Wound Healing | Q42427994 | ||
| Association of chronic hydrocephalus after aneurysmal subarachnoid hemorrhage with transforming growth factor-β1 levels and other risk factors | Q43412729 | ||
| Function and regulation of production of hepatocyte growth factor (HGF) | Q44025036 | ||
| Novel epidemiological features of moyamoya disease | Q45359770 | ||
| Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease. | Q46190570 | ||
| Differences in cellular responses to mitogens in arterial smooth muscle cells derived from patients with moyamoya disease | Q47976063 | ||
| Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders | Q48475557 | ||
| Histopathology of the brain vascular network in moyamoya disease | Q48810229 | ||
| Levels of soluble adhesion molecules are elevated in the cerebrospinal fluid of children with moyamoya syndrome. | Q51335662 | ||
| Clinical features of familial moyamoya disease. | Q51838971 | ||
| Down-regulation of Platelet-Derived Growth Factor-D Inhibits Cell Growth and Angiogenesis through Inactivation of Notch-1 and Nuclear Factor-κB Signaling | Q56648795 | ||
| Moyamoya disease in children | Q57226720 | ||
| Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease | Q58409049 | ||
| Recombinant human granulocyte colony stimulating factor: molecular and biological characterization | Q68812481 | ||
| Angiogenic factors in moyamoya disease | Q71905100 | ||
| Basic fibroblast growth factor in human saliva: detection and physiological implications | Q72285741 | ||
| The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor | Q72624851 | ||
| Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease | Q72659278 | ||
| Moyamoya disease | Q73090978 | ||
| Linkage analysis of moyamoya disease on chromosome 6 | Q73658136 | ||
| Increase in elastin gene expression and protein synthesis in arterial smooth muscle cells derived from patients with Moyamoya disease | Q73711214 | ||
| Moyamoya disease in Europe, past and present status | Q73966189 | ||
| Familial occurrence of moyamoya disease | Q73966237 | ||
| Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease | Q77371696 | ||
| Expression of hypoxia-inducing factor-1 alpha and endoglin in intimal hyperplasia of the middle cerebral artery of patients with Moyamoya disease | Q79750860 | ||
| Pathological and immunohistochemical findings of an autopsy case of adult moyamoya disease | Q80862275 | ||
| Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease | Q80968092 | ||
| Expression of vascular endothelial growth factor in dura mater of patients with moyamoya disease | Q81388515 | ||
| Clinical significance of the transitional phase at gadoxetate disodium-enhanced hepatic MRI for the diagnosis of hepatocellular carcinoma: preliminary results | Q82499903 | ||
| Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease | Q83193829 | ||
| Exogenous basic fibroblast growth factor inhibits ER stress-induced apoptosis and improves recovery from spinal cord injury | Q85233142 | ||
| Comparative study of the effects of recombinant human epidermal growth factor and basic fibroblast growth factor on corneal epithelial wound healing and neovascularization in vivo and in vitro | Q85756687 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 105 | |
| P577 | publication date | 2013-08-14 | |
| P1433 | published in | Frontiers in Neurology | Q15817039 |
| P1476 | title | Is there a role for treating inflammation in moyamoya disease?: a review of histopathology, genetics, and signaling cascades | |
| P478 | volume | 4 |
| Q33780428 | Association of increased Treg and Th17 with pathogenesis of moyamoya disease |
| Q38412128 | Caveolin-1, Ring finger protein 213, and endothelial function in Moyamoya disease. |
| Q41839757 | Functional cortical and cerebellar reorganization in a case of moyamoya disease |
| Q89174673 | Significance of cyclooxygenase-2 elevation in middle cerebral artery for patients with hemorrhagic moyamoya disease |
| Q26769012 | The Pathophysiology of Moyamoya Disease: An Update |
Search more.